Press release
Primary Aldosteronism Market Key Players, Trends & Forecast to 2034
Primary Aldosteronism Market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/51974
1. What Is Primary Aldosteronism? (Keyword Definition)
Primary Aldosteronism (PA), also known as Conn's Syndrome, is a hormonal disorder characterized by excess production of aldosterone from the adrenal glands. This leads to:
• Resistant hypertension
• Low potassium (hypokalemia)
• Muscle weakness
• Fatigue
• Increased cardiovascular risk
PA is primarily caused by:
• Aldosterone-producing adenoma (APA)
• Bilateral adrenal hyperplasia (BAH)
• Adrenal carcinoma (rare)
• Familial hyperaldosteronism genetic variants
Diagnosis relies on aldosterone-renin ratio (ARR) testing, confirmatory suppression tests, CT imaging, and adrenal vein sampling (AVS).
2. Key Players in the Market
Companies active in endocrine diagnostics, antihypertensive therapy, and adrenal imaging include:
• Pfizer Inc.
• Novartis AG
• Bayer AG
• Merck & Co., Inc.
• Teva Pharmaceuticals
• AstraZeneca
• GE Healthcare (medical imaging)
• Siemens Healthineers (hormonal testing systems)
• Abbott Laboratories
• Medtronic plc
These companies provide hormonal assays, mineralocorticoid receptor antagonists, diagnostic devices, and imaging solutions used in PA management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/51974/primary-aldosteronism-market
3. Key Events in the Last 5 Years
Recent advances influencing the Primary Aldosteronism Market include:
• Increased global screening recommendations for resistant hypertension.
• Improved accuracy of ARR testing and automated lab platforms.
• Greater use of adrenal vein sampling (AVS) for subtype differentiation.
• Expansion of minimally invasive adrenalectomy with improved outcomes.
• New research on familial hyperaldosteronism genetic mutations.
• Growing awareness of PA's link to cardiovascular complications.
• Development of next-generation mineralocorticoid antagonists with fewer side effects.
4. Market Growth Rate (CAGR & Forecast)
The Primary Aldosteronism Market is projected to grow at a CAGR of 6%-8% between 2024 and 2034.
Growth drivers include:
• Rising prevalence of resistant hypertension, especially in aging populations
• Improved diagnostic capabilities and increased screening
• Expanding adoption of targeted therapy (MRAs)
• Greater availability of minimally invasive adrenal surgery
• Wider recognition of PA as a highly treatable endocrine cause of hypertension
By 2034, the market is expected to achieve a multi-billion-dollar valuation globally.
5. Market Segments & Growth Analysis
By Disease Type
• Aldosterone-Producing Adenoma (APA) - Requires adrenalectomy; significant share.
• Bilateral Adrenal Hyperplasia (BAH) - Managed primarily with medication.
• Familial Hyperaldosteronism (FH) - Growing diagnostic awareness.
• Adrenocortical Carcinoma - Rare but severely progressive segment.
By Treatment
• Mineralocorticoid Receptor Antagonists (MRAs)
o Spironolactone
o Eplerenone (well-tolerated, selective)
• Adrenalectomy (Surgical)
o Laparoscopic adrenalectomy
o Robotic adrenalectomy
• Supportive Therapy
o Antihypertensives
o Potassium supplements
o Dietary sodium management
• Genetic Counseling & Monitoring - Increasing adoption in hereditary cases.
By Diagnostic Method
• Aldosterone-Renin Ratio (ARR) - Primary screening tool.
• Confirmatory Suppression Tests - Oral sodium loading, saline infusion.
• CT/MRI Imaging - Used to identify adrenal abnormalities.
• Adrenal Vein Sampling (AVS) - Gold standard for subtype differentiation.
• Genetic Testing - Emerging for familial forms.
By End User
• Hospitals - Major centers for diagnostic evaluation and surgery.
• Endocrinology Clinics - Core for long-term management.
• Diagnostic Laboratories - High demand for hormonal assays.
• Ambulatory Centers - Increasing use for imaging and follow-up care.
By Region
• North America - Strong adoption of hormonal assays and AVS.
• Europe - High screening rates for resistant hypertension.
• Asia-Pacific - Fastest-growing due to rising hypertension burden.
• Latin America & MEA - Improving diagnostic access and awareness.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=51974
6. Key Market Drivers
• Global surge in hypertension and cardiovascular disease cases.
• Growing physician awareness of PA as a treatable hypertension cause.
• Improved availability of MRAs reducing long-term complications.
• Advances in imaging and AVS, improving subtype classification.
• Government healthcare initiatives promoting hypertension screening.
• Increase in genetic testing for familial forms.
• Rising demand for minimally invasive adrenal surgery with high cure rates.
7. Conclusion
The Primary Aldosteronism Market is expanding steadily as early detection of hormonal hypertension becomes a clinical priority. With advanced diagnostics, better antihypertensive therapies, and increased global screening efforts, the market is expected to experience strong growth through 2034. Innovations in genetic testing, surgical techniques, and precision endocrine care will further enhance outcomes for patients worldwide.
This report is also available in the following languages : Japanese (原発性アルドステロン症市場), Korean (원발성 알도스테론증 시장), Chinese (原发性醛固酮增多症市场), French (Marché primaire de l'aldostéronisme), German (Primärer Aldosteronismus-Markt), and Italian (Mercato dell'aldosteronismo primario), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/51974/primary-aldosteronism-market#request-a-sample
Our More Reports:
Diabetic Nephropathy Market
https://exactitudeconsultancy.com/reports/51988/diabetic-nephropathy-market
Parotid Tumors Market
https://exactitudeconsultancy.com/reports/51990/parotid-tumors-market
Hemophilia Treatment Market
https://exactitudeconsultancy.com/reports/51992/hemophilia-treatment-market
Narcolepsy Market
https://exactitudeconsultancy.com/reports/51994/narcolepsy-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Aldosteronism Market Key Players, Trends & Forecast to 2034 here
News-ID: 4276207 • Views: …
More Releases from Exactitude Consultancy
Sharps and Clinical Waste Container Market Overview and Future Outlook
Market Overview
• The market covers containers designed for sharps (needles, syringes, lancets) and clinical waste (biohazard bags, infectious waste bins, hazardous-waste containers) used in hospitals, clinics, laboratories, and other healthcare settings.
• According to related studies, the sharps-only segment was valued at about USD 362.46 million in 2024 and projected to grow at a CAGR of ~4.9% (2025-2030).
• The broader medical waste container market (including sharps, biohazard, chemo containers etc.) was estimated at…
Ultra-low Temperature Vaccine Freezer Market Trends, Analysis, and Forecast
Market Overview
• The market addresses ultra-low temperature (ULT) freezers specifically used for vaccine storage - i.e., freezers capable of maintaining very low temperatures (e.g., -70 °C or below) to preserve sensitive biologic vaccines and therapies.
• It is positioned within the wider vaccine cold-chain and medical storage equipment sector, increasingly critical due to advanced vaccines (e.g., mRNA) that demand extreme cold conditions.
• According to one industry estimate, the ULT freezer market was about USD…
Supermarket Anti-theft System Market Growth and Opportunities
Market Snapshot
• The market is estimated to be valued at around USD 1.85 billion in 2025, and is projected to grow to approximately USD 3.2 billion by 2032, representing a CAGR of about 8.3% from 2025 to 2032.
• Other related estimates for the broader supermarket/retail anti-theft system space place the market at ~USD 2.5 billion in 2023 for devices and projecting to ~USD 4.6 billion by 2032.
• The market is driven…
PTFE Anti-drip Agent Market Overview and Future Outlook
Market Snapshot
• The market size in 2024 is estimated at ≈ USD 220 million.
• It is expected to grow significantly from this base, supported by rising demand for flame retardant additives and anti-dripping agents in multiple end-use industries.
• The growth rate (CAGR) is moderate to strong depending on region and segment.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/53905
What are PTFE Anti-Drip Agents?
PTFE (polytetrafluoroethylene) anti-drip agents are specialty additives used in polymer…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
